மையம் க்கு த்ரோம்போசிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மையம் க்கு த்ரோம்போசிஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மையம் க்கு த்ரோம்போசிஸ் Today - Breaking & Trending Today

Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer

Search jobs
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Actimed Therapeutics, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, today announces the appointment of Frank Misselwitz MD, PhD, as Chief Medical Officer.
Dr Misselwitz joins the Company in his new role from Bayer AG where until recently he was Corporate Vice President and Therapeutic Area Head in clinical development. With a background in academia and industry, he has over 30 years of extensive pharmaceutical industry experience. Dr Misselwitz is currently a non-executive director and member of the Board of Actimed. ....

United States , United Kingdom , Robin Bhattacherjee , Bayer Ag , Haemostasis University Of Mainz , German Centre For Cardiovascular Research , Centre For Thrombosis , Actimed Therapeutics , Frank Misselwitz , Chief Medical , Corporate Vice President , Therapeutic Area Head , Scientific Advisory Board , German Centre , Cardiovascular Research , Haemostasis University , Chief Medical Officer , Therapeutic Area , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஜெர்மன் மையம் க்கு இருதய ஆராய்ச்சி , மையம் க்கு த்ரோம்போசிஸ் , தலைமை மருத்துவ , பெருநிறுவன துணை ப்ரெஸிடெஂட் , சிகிச்சை பரப்பளவு தலை , ஜெர்மன் மையம் ,

Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer

Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Joins Actimed following highly successful 20-year career at Bayer
News provided by
Share this article
Share this article
LONDON, Feb. 2, 2021 /PRNewswire/ Actimed Therapeutics, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, today announces the appointment of Frank Misselwitz MD, PhD, as Chief Medical Officer.
Dr Misselwitz joins the Company in his new role from Bayer AG where until recently he was Corporate Vice President and Therapeutic Area Head in clinical development. With a background in academia and industry, he has over 30 years of extensive pharmaceutical industry experience. Dr Misselwitz is currently a non-executive director and member of the Board of Actimed. ....

United States , United Kingdom , City Of , Frazer Hall , Robin Bhattacherjee , Stefan Anker , Nathaniel Dahan , Citigate Dewe Rogerson , Bayer Ag , Haemostasis University Of Mainz , German Centre For Cardiovascular Research , Centre For Thrombosis , Actimed Therapeutics , Frank Misselwitz , Chief Medical , Corporate Vice President , Therapeutic Area Head , Scientific Advisory Board , German Centre , Cardiovascular Research , Haemostasis University , Chief Medical Officer , Therapeutic Area , Andrew Coats , Non Small Cell Lung Cancer , Colorectal Cancer ,